Target intelligence / Profile preview

PAPPA antisense RNA 2 (PAPPA-AS2)

Target
PAPPA-AS2
Molecular classification
Other, long non-coding RNA, lncRNA
01

Overview

PAPPA antisense RNA 2 (PAPPA-AS2) is a long non-coding RNA (lncRNA) transcribed from the PAPPA gene locus in the antisense orientation. It is also known as AGU1 or adipogenesis up-regulated transcript 1, reflecting its upregulation during adipogenic differentiation in certain cell models. As a lncRNA, PAPPA-AS2 does not encode a protein. It is hypothesized to play a regulatory role in gene expression, especially in adipogenesis, and has emerging evidence associating its dysregulation with cancer. There is currently no evidence that PAPPA-AS2 is a direct target of approved small molecules or biologics, nor is it classified as a receptor, enzyme, or other common drug target class. Instead, PAPPA-AS2 fits within the growing class of regulatory lncRNAs involved in cell differentiation, proliferation, and disease, and may serve as a putative biomarker or future therapeutic target in oncology and metabolic disease contexts (information inferred from similar lncRNAs and their roles in cancer and adipogenesis).

Other names
AGU1adipogenesis up-regulated transcript 1PAPPA-AS2
02

Mechanism of action

Not applicable (no known pharmacological modulators)

03

Biological functions

Regulation of adipogenesismodulation of gene expression
04

Disease associations

CancerMetabolic disorders
05

Safety considerations

None establishedStandard RNA-targeted therapeutic challenges may apply (off-target effects, delivery, specificity)
06

Biomarkers

None specifically validated for patient selection or efficacy monitoringPotential as a biomarker for cancer

Beyond the preview

Go deeper on PAPPA antisense RNA 2 (PAPPA-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PAPPA antisense RNA 2 (PAPPA-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call